Cadence 215

Category: Drug Studies for the Heart

Start Date: 06/07/2012

Determines the safety, tolerability, pharmacokinetics and efficacy of intravenous infusions of OPC-108459 administered to patients with paroxysmal and persistent atrial fibrillation. Part 1 of this study will determine the maximally tolerated dose of OPC-108459 in patients with paroxysmal and persistent atrial fibrillation. Part 2 will determine potential efficacy of dose(s) of OPC-108459 for the treatment of paroxysmal and persistent atrial fibrillation

Contact the research coordinator: Tamithy Huber